<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This position paper of the Section of Gastrointestinal <z:hpo ids='HP_0002664'>Oncology</z:hpo> of the Israeli Gastroenterological Association recommends specific guidelines for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> surveillance in patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is a severe complication of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), generally developing into a longstanding disease </plain></SENT>
<SENT sid="2" pm="."><plain>The Lifetime prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) patients is estimated to be 2% after 10 years, 8% after 20 years, and even 18% after 30 years of <z:e sem="disease" ids="C0849867" disease_type="Disease or Syndrome" abbrv="">extensive disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Screening colonoscopy should be initiated 8-10 years after <z:hpo ids='HP_0003674'>onset</z:hpo> of symptoms in extensive UC patients (<z:e sem="disease" ids="C0868908" disease_type="Disease or Syndrome" abbrv="">pancolitis</z:e>), and after 15 years in patients with left-sided <z:hpo ids='HP_0002583'>colitis</z:hpo> (UC or Crohn's) </plain></SENT>
<SENT sid="4" pm="."><plain>Surveillance should continue periodically at an interval of every 1 to 2 years </plain></SENT>
<SENT sid="5" pm="."><plain>Surveillance colonoscopies should be performed in combination with an extensive biopsy protocol </plain></SENT>
<SENT sid="6" pm="."><plain>High-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) in flat mucosa or a <z:mpath ids='MPATH_589'>dysplasia</z:mpath> associated Lesion or mass (DALM) is considered an indication for colectomy when the pathological findings are confirmed by a second experienced pathologist </plain></SENT>
<SENT sid="7" pm="."><plain>Further research is directed toward improving detection of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> during colonoscopy through the use of novel endoscopic imaging techniques which are hoped to impact the approach to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention in patients with IBD </plain></SENT>
</text></document>